Table 2.
Comparison of characteristics between patients with and without complete remission at 12 months follow up.
| Disappearance | Appearance | t/Z | P | |
|---|---|---|---|---|
| Number | 12 | 22 | ||
| Age (years) | 34.46 ± 9.57 | 39.32 ± 14.53 | -1.072 | 0.291 |
| Largest diameter (cm) | 0.46 ± 0.14 | 0.59 ± 0.15 | -2.426 | 0.021 |
| Volume (cm3) | 0.04 (0.01, 0.04) | 0.11 (0.05, 0.12) | 2.799 | 0.004 |
| Distance from the nearest capsule (cm) | 0.07 ± 0.08 | 0.11 ± 0.10 | -1.299 | 0.203 |
| Distance from the dorsal capsule (cm) | 0.31 ± 0.30 | 0.26 ± 0.22 | 0.546 | 0.589 |
| Ablated time (s) | 63.00 (45.00, 104.00) | 70.50 (45.00, 82.00) | -0.017 | 0.987 |
| Ablated volume (cm3) | 1.22 ± 0.75 | 1.55 ± 0.96 | -1.060 | 0.297 |
| Energy (J) | 1650.00 (1350.00, 3120.00) | 2115.00 (1350.00, 2460.00) | 0.068 | 0.960 |
| Energy/volume (J/ml) | 89825.25 (32553.32, 134024.22) | 23213.86 (12570.99, 43798.03) | -2.629 | 0.008 |
| TSH (µIU/ml) | 1.97 (1.36, 3.04) | 1.59 (1.29, 2.94) | -0.656 | 0.529 |
| FT4 (pmol/l) | 16.80 ± 2.22 | 16.01 ± 2.59 | 0.907 | 0.371 |
| FT3 (pmol/l) | 4.82 ± 0.49 | 4.86 ± 0.48 | -0.246 | 0.808 |